Literature DB >> 8200980

Two subsets of HLA-DQA1 alleles mark phenotypic variation in levels of insulin autoantibodies in first degree relatives at risk for insulin-dependent diabetes.

A Pugliese1, T Bugawan, R Moromisato, Z L Awdeh, C A Alper, R A Jackson, H A Erlich, G S Eisenbarth.   

Abstract

Levels of insulin autoantibodies (IAA) vary among different first degree relatives of insulin-dependent diabetes mellitus patients, suggesting genetic regulation. We previously reported elevated IAA among DR4-positive at risk relatives. In this study, 72/82 at risk relatives were IAA positive, of whom 75% (54/72) carried DR4 versus 20% (2/10) of IAA-negative relatives (P = 0.0004). However, 69% (18/26) of DR4-negative relatives were IAA positive. Since DR4 did not account for all IAA positivity, we analyzed DQA1 and DQB1 alleles. Homozygosity for DQA1 alleles deriving from the evolutionary lineage 4 (*0401, *0501, *0601) was associated with low IAA levels, while lineage 1-3 alleles (*0101, *0102, *0103, *0201, *0301) correlated with higher levels. Most (93%, 65/70) relatives with lineage 1-3 alleles were IAA positive (mean = 360 +/- 63 SEM nU/ml). Only 7/12 relatives homozygous for lineage 4 alleles were IAA-positive, with lower levels than relatives with lineage 1-3 alleles (mean = 55 +/- 15 SEM nU/ml, P < 0.0001; 7/12 vs 65/70, P = 0.004). The amino acid sequences of lineage 1-3 alleles uniquely share glutamic acid (E) and phenylalanine (F) at positions 40 and 51 (EF alleles). Lineage 4 alleles have glycine (G) and leucine (L) at those positions (GL alleles). 90% (65/72) of IAA-positive relatives had an EF allele, while only 75% (54/72) had DR4 (P = 0.01). Homozygosity for GL alleles (often DQA1 *0501 on DR3 haplotypes) correlated with little or no humoral response to insulin. Thus, HLA-DQB1 GL alleles, or other genes on haplotypes (e.g., DR3) that carry these DQA1 alleles, may confer recessive low responsiveness to insulin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200980      PMCID: PMC294453          DOI: 10.1172/JCI117253

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

Review 1.  Type I diabetes mellitus: lessons for human autoimmunity.

Authors:  A Pugliese; G S Eisenbarth
Journal:  J Lab Clin Med       Date:  1992-09

2.  Assay for islet cell antibodies. Protein A--monoclonal antibody method.

Authors:  S Srikanta; A Rabizadeh; M A Omar; G S Eisenbarth
Journal:  Diabetes       Date:  1985-03       Impact factor: 9.461

3.  Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes.

Authors:  R K Saiki; T L Bugawan; G T Horn; K B Mullis; H A Erlich
Journal:  Nature       Date:  1986 Nov 13-19       Impact factor: 49.962

4.  HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus.

Authors:  J A Todd; J I Bell; H O McDevitt
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

5.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

6.  Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.

Authors:  R Gianani; A Pugliese; S Bonner-Weir; A J Shiffrin; J S Soeldner; H Erlich; Z Awdeh; C A Alper; R A Jackson; G S Eisenbarth
Journal:  Diabetes       Date:  1992-03       Impact factor: 9.461

7.  Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).

Authors:  J D Reveille; D Owerbach; R Goldstein; R Moreda; R A Isern; F C Arnett
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

8.  Anti-insulin antibodies in children with type I diabetes mellitus. Genetic regulation of production and presence at diagnosis before insulin replacement.

Authors:  R C McEvoy; M E Witt; F Ginsberg-Fellner; P Rubinstein
Journal:  Diabetes       Date:  1986-06       Impact factor: 9.461

9.  Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type I diabetes mellitus.

Authors:  P Vardi; S A Dib; M Tuttleman; J E Connelly; M Grinbergs; A Radizabeh; W J Riley; N K Maclaren; G S Eisenbarth; J S Soeldner
Journal:  Diabetes       Date:  1987-11       Impact factor: 9.461

Review 10.  Insulin autoimmunity: the rate limiting factor in pre-type I diabetes.

Authors:  G S Eisenbarth; R A Jackson; A Pugliese
Journal:  J Autoimmun       Date:  1992-04       Impact factor: 7.094

View more
  7 in total

Review 1.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population.

Authors:  Yoshiki Itoh; Nobuhisa Mizuki; Tsuyako Shimada; Fumihiro Azuma; Mitsuo Itakura; Koichi Kashiwase; Eri Kikkawa; Jerzy K Kulski; Masahiro Satake; Hidetoshi Inoko
Journal:  Immunogenetics       Date:  2005-11-08       Impact factor: 2.846

Review 3.  Autoantigens in type 1 diabetes mellitus.

Authors:  F Dotta; E Anastasi; C Tiberti; U Di Mario
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

4.  Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis.

Authors:  E di Cesare; M Previti; F Russo; S Brancatelli; M C Ingemi; R Scoglio; N Mazzù; D Cucinotta; G Raimondo
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

Review 5.  Multiple genes/multiple autoantigens role in type 1 diabetes.

Authors:  N Abiru; G S Eisenbarth
Journal:  Clin Rev Allergy Immunol       Date:  2000-02       Impact factor: 10.817

6.  Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function.

Authors:  Sergio A Dib; Marilia B Gomes
Journal:  Diabetol Metab Syndr       Date:  2009-12-04       Impact factor: 3.320

7.  George S. Eisenbarth: insulin and type 1 diabetes.

Authors:  Alberto Pugliese; Jay S Skyler
Journal:  Diabetes Care       Date:  2013-06       Impact factor: 19.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.